Notably, although KRAS mutations are some of the most frequent genetic mutations in human cancers 3, particularly in CRC, the dysregulated miRNAs and their functions and underlying mechanisms following KRAS mutation have yet to be fully explored. The gene discussed is KRAS; the disease is cancer.